Food and Drug Administration Expert Panel on Infant Formula “Operation Stork Speed”

Why It Matters

With 73 % of U.S. infants relying on formula, modernizing standards directly impacts child health and market competition, while addressing longstanding safety and nutrition gaps.

Key Takeaways

• Half of U.S. formulas replace lactose with corn syrup solids
• FDA guidelines lack upper limits for calcium, phosphorus, and iron
• Proposed centralized FDA formula database to aid caregivers
• New Approach Methods replace outdated protein growth testing
• Preterm formula innovation remains limited despite NICU needs

Pulse Analysis

Infant formula remains a lifeline for roughly 73 % of American babies, many of whom rely on it exclusively during the first half‑year. Yet the regulatory framework governing these products has changed little since the 1980s, creating a gap between modern nutrition science and the standards that protect the most vulnerable consumers. In March 2025 the Food and Drug Administration launched Operation Stork Speed, a multi‑year effort to overhaul formula guidelines based on four decades of research. By convening an interdisciplinary panel in June, the agency signaled a decisive shift toward evidence‑driven policy.

The panel’s three‑part report highlights concrete deficiencies in current formulas. More than 50 % of U.S. products substitute lactose with corn‑based glucose polymers, a practice linked to excess weight gain and altered gut microbiota in observational studies. Micronutrient analysis calls for reduced iron levels and caps on calcium and phosphorus, aligning U.S. standards with European recommendations. Safety protocols also face overhaul: the FDA’s legacy protein‑growth tests will be supplanted by New Approach Methods such as human infant gut enteroid screens and neonatal swine models, promising faster, more predictive assessments of novel ingredients.

Modernizing the regulatory landscape could unlock significant market dynamics. A centralized FDA formula database would give clinicians and parents transparent, evidence‑based product comparisons, while streamlined approval pathways may encourage startups to introduce innovative, specialty formulas—particularly for preterm infants who currently depend on limited, often inaccessible options. By reducing health disparities and fostering competition, Operation Stork Speed aims to raise the nutritional ceiling for all infants, reinforcing human milk as the gold standard while ensuring formula serves as a safe, scientifically optimized backup. Industry stakeholders are watching closely as the FDA drafts its final rulebook.